ConductScience.org, home

Paper2014996

Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media.

Stringfellow WT and 3 others. Appl Environ Microbiol, 1991. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media. Papers, record 2014996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2014996

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media.
PubMed
Journal
Appl Environ Microbiol
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stringfellow WTW T
2Dassy BB
3Lieb MM
4Fournier JMJ M

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial CapsulesMajor topic
Polysaccharides, BacterialMajor topic
Staphylococcus aureusMajor topic
Carbohydrate Metabolism
Culture Media
Energy Metabolism

Source PubMed

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,977,282Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.J Exp Med1969https://conductscience.org/library/papers/4977282PubMed
2234,506Glucose repression of enterotoxins A, B and C and other extracellular proteins in staphlyococci in batch and continuous culture.J Gen Microbiol1975https://conductscience.org/library/papers/234506PubMed
33,125,849Isolation of type 5 capsular polysaccharide from Staphylococcus aureus.Ann Inst Pasteur Microbiol1987https://conductscience.org/library/papers/3125849PubMed
41,125,861Amino acid requirements of staphylococci isolated from human skin.Can J Microbiol1975https://conductscience.org/library/papers/1125861PubMed
52,753,836Amino acid requirements for the growth and production of some exocellular products of Staphylococcus aureus.J Appl Bacteriol1989https://conductscience.org/library/papers/2753836PubMed
64,200,860Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.J Bacteriol1973https://conductscience.org/library/papers/4200860PubMed
724,085Exopolysaccharide production by Pseudomonas NCIB11264 grown in continuous culture.J Gen Microbiol1978https://conductscience.org/library/papers/24085PubMed
82,745,705Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus.J Clin Microbiol1989https://conductscience.org/library/papers/2745705PubMed
93,230,130Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis.J Clin Microbiol1988https://conductscience.org/library/papers/3230130PubMed
112,754,004Staphylococcus aureus strains which are not identified by rapid agglutination methods are of capsular serotype 5.J Clin Microbiol1989https://conductscience.org/library/papers/2754004PubMed
123,068,181Bacterial surface polysaccharides: structure and function.Int Rev Cytol1988https://conductscience.org/library/papers/3068181PubMed
137,365,450Extracellular polysaccharide biosynthesis by Pseudomonas NCIB 11264. Studies on precursor-forming enzymes and factors affecting exopolysaccharide production by washed suspensions.J Gen Microbiol1980https://conductscience.org/library/papers/7365450PubMed
143,667,914Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus.J Clin Microbiol1987https://conductscience.org/library/papers/3667914PubMed
153,930,565Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus.J Clin Microbiol1985https://conductscience.org/library/papers/3930565PubMed
164,715,560Amino acid requirements for the production of enterotoxin B by Staphylococcus aureus S-6 in a chemically defined medium.Appl Microbiol1973https://conductscience.org/library/papers/4715560PubMed
1716,347,752Effect of Nitrogen on Polysaccharide Production in a Porphyridium sp.Appl Environ Microbiol1988https://conductscience.org/library/papers/16347752PubMed
18669,789Molar growth yields and enterotoxin B production of Staphylococcus aureus S-6 with amino acids as energy sources.Infect Immun1978https://conductscience.org/library/papers/669789PubMed
1996,088Biosynthesis of exopolysaccharide by Pseudomonas aeruginosa.J Bacteriol1978https://conductscience.org/library/papers/96088PubMed
202,437,148Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8.J Clin Microbiol1987https://conductscience.org/library/papers/2437148PubMed
213,052,752Bacterial extracellular polysaccharides.Can J Microbiol1988https://conductscience.org/library/papers/3052752PubMed

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
29,725,989Survey of potential factors involved in the low frequency of CP5 and CP8 expression in Staphylococcus aureus isolates from mastitis of dairy cattle from Argentina, Chile, and Uruguay.J Appl Genet2018https://conductscience.org/library/papers/29725989PubMed
24,453,967Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose.PLoS Pathog2014https://conductscience.org/library/papers/24453967PubMed
20,065,327
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.
Clin Microbiol Rev2010https://conductscience.org/library/papers/20065327PubMed
16,048,934Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16048934PubMed
14,726,462Staphylococcus aureus capsular polysaccharides.Clin Microbiol Rev2004https://conductscience.org/library/papers/14726462PubMed
10,948,098Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase.Infect Immun2000https://conductscience.org/library/papers/10948098PubMed
10,921,967Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States.J Clin Microbiol2000https://conductscience.org/library/papers/10921967PubMed
10,655,395Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.J Clin Microbiol2000https://conductscience.org/library/papers/10655395PubMed
10,496,870Development and characterization of a Staphylococcus aureus nasal colonization model in mice.Infect Immun1999https://conductscience.org/library/papers/10496870PubMed
10,488,184Slime production and expression of the slime-associated antigen by staphylococcal clinical isolates.J Clin Microbiol1999https://conductscience.org/library/papers/10488184PubMed
10,198,014Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.J Bacteriol1999https://conductscience.org/library/papers/10198014PubMed
9,784,520Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.Infect Immun1998https://conductscience.org/library/papers/9784520PubMed
9,673,297Synthesis of microcapsule by Staphylococcus aureus is not responsive to environmental phosphate concentrations.Infect Immun1998https://conductscience.org/library/papers/9673297PubMed
9,144,363Heterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.Clin Diagn Lab Immunol1997https://conductscience.org/library/papers/9144363PubMed
8,698,459Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.Infect Immun1996https://conductscience.org/library/papers/8698459PubMed
8,613,375A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.Infect Immun1996https://conductscience.org/library/papers/8613375PubMed
8,501,240New latex reagent using monoclonal antibodies to capsular polysaccharide for reliable identification of both oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus.J Clin Microbiol1993https://conductscience.org/library/papers/8501240PubMed
8,368,833Effects of nutrients on exopolysaccharide production and surface properties of Aeromonas salmonicida.Appl Environ Microbiol1993https://conductscience.org/library/papers/8368833PubMed
7,697,524Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.Clin Diagn Lab Immunol1995https://conductscience.org/library/papers/7697524PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2014996

GET https://conductscience.org/api/papers/v1/2014996/authors